Plaintiffs Want Pfizer Celebrex Docs Unsealed

Law360, New York (June 9, 2009, 12:00 AM EDT) -- Plaintiffs in the securities fraud class action against Pfizer Inc. accusing the company of making materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex have asked the court to overturn an order they claim allows “unwarranted sealing” of documents.

In a motion filed Monday in the U.S. District Court for the District of New Jersey, plaintiffs argued that the public’s right to access court documents trumps the “self-critical analysis privilege” that has allowed Pfizer to keep court documents such as class certification and...
To view the full article, register now.